Care for COVID-19 Act [HB-6311]
[Healthcare ]
[Insurance ]
[Public Health ]
Requires private health insurance plans to cover, without any cost-sharing requirement, inpatient and outpatient services related to the diagnosis, care, and treatment of COVID-19 (i.e., coronavirus disease 2019). The bill further provides a special enrollment period for individuals who are diagnosed with, or presumed diagnosed with, COVID-19 to obtain coverage through (1) the individual or group marketplace, (2) a health insurance exchange, or (3) an employer-funded health plan.
HB-6311: Care for COVID-19 Act
Sponsored by: Rep. Raul Ruiz
Introduced In House on 03/19/2020
Care for COVID-19 Act [HB-6311]
[Healthcare ]
[Insurance ]
[Public Health ]
Requires private health insurance plans to cover, without any cost-sharing requirement, inpatient and outpatient services related to the diagnosis, care, and treatment of COVID-19 (i.e., coronavirus disease 2019). The bill further provides a special enrollment period for individuals who are diagnosed with, or presumed diagnosed with, COVID-19 to obtain coverage through (1) the individual or group marketplace, (2) a health insurance exchange, or (3) an employer-funded health plan.
HB-6311: Care for COVID-19 Act
Sponsored by: Rep. Raul Ruiz
Introduced In House on 03/19/2020
Rapid Coverage for Coronavirus Vaccines Act [S.3505]
[Healthcare ]
[Insurance ]
[Public Health ]
Shortens the time frame under which private health insurance plans must cover certain new preventative services related to COVID-19 (i.e., coronavirus disease 2019). Under current law, health plans have one year to cover services recommended by the United States Preventive Services Task Force or the Advisory Committee on Immunization Practices. Under this bill, health plans must cover such services to prevent or diagnose COVID-19 within 15 days.
S.3505: Rapid Coverage for Coronavirus Vaccines Act
Sponsored by: Sen. Steve Daines
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/17/2020
Tribal Medical Supplies Stockpile Access Act of 2020 [S.3514]
[Healthcare ]
[Public Health ]
[Native American Affairs ]
[Pharmaceuticals ]
[Disaster Relief ]
[Funding ]
[Grants ]
Requires the Department of Health and Human Services (HHS) to deploy drugs, vaccines, biological products, medical devices, and other supplies from the Strategic National Stockpile directly to health programs or facilities operated by the Indian Health Service (IHS), tribes, or tribal organizations. Such supplies from the stockpile are used to respond to public health emergencies. Specifically, if HHS distributes pandemic or epidemic products (e.g., drugs or medical devices) to states or other entities, HHS must also deploy such products directly
(continued...)
S.3514: Tribal Medical Supplies Stockpile Access Act of 2020
Sponsored by: Sen. Elizabeth Warren
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/17/2020
Ensuring Access to COVID-19 Preventive Care Act of 2020 [HB-6231]
[Healthcare ]
[Public Health ]
[Insurance ]
Requires private health insurance plans to cover diagnostic tests for COVID-19 (i.e., coronavirus disease 2019) without imposing cost sharing. The requirement applies only: (1) to tests designated by the Department of Health and Human Services, and (2) during the public health emergency declared on January 31, 2020.The bill also shortens to 15 business days the time frame under which the Advisory Committee on Immunization Practices must issue a recommendation after a vaccine intended to treat or prevent COVID-19 is licensed by the Food and Drug
(continued...)
HB-6231: Ensuring Access to COVID-19 Preventive Care Act of 2020
Sponsored by: Rep. Janice Schakowsky
Introduced In House on 03/12/2020
Crowdfunding to Combat the Coronavirus Act [HB-6253]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
[Science ]
[Technology and Innovation ]
[Funding ]
[Grants ]
[Small Business ]
[Cybersecurity ]
[Economic Development ]
(1) establishes an award for the successful development of a vaccine for the coronavirus (i.e., the virus that causes COVID-19), and (2) extends specified Securities and Exchange Commission (SEC) registration exemptions to issuers of securities responding to the COVID-19 outbreak. The bill provides appropriations for the purpose of awarding a prize to the creator of a vaccine that (1) reduces the incidence and mortality rate of COVID-19 by more than 50%, and (2) is affordable and widely available to the public. Additionally, an issuer of securities
(continued...)
HB-6253: Crowdfunding to Combat the Coronavirus Act
Sponsored by: Rep. Ann Wagner
Introduced In House on 03/12/2020
Ensuring Affordable COVID-19 Preventive Care Act of 2020 [HB-6222]
[Healthcare ]
[Insurance ]
[Public Health ]
Shortens the time frame under which private health insurance plans must cover certain new preventative services related to COVID-19 (i.e., coronavirus disease 2019). Under current law, health plans have one year to cover services recommended by the United States Preventive Services Task Force or the Advisory Committee on Immunization Practices. Under this bill, health plans must cover such services to prevent, diagnose, and treat COVID-19 within 15 days.
HB-6222: Ensuring Affordable COVID-19 Preventive Care Act of 2020
Sponsored by: Rep. Janice Schakowsky
Introduced In House on 03/12/2020
Care for COVID–19 Act [S.3442]
[Healthcare ]
[Insurance ]
[Public Health ]
Requires private health insurance plans to cover, without any cost-sharing requirement, inpatient and outpatient services related to the diagnosis, care, and treatment of COVID-19 (i.e., coronavirus disease 2019). The bill further provides a special enrollment period for individuals who are diagnosed with, or presumed diagnosed with, COVID-19 to obtain coverage through (1) the individual or group marketplace, (2) a health insurance exchange, or (3) an employer-funded health plan.
S.3442: Care for COVID–19 Act
Sponsored by: Sen. Cory Booker
Read Twice And Referred To The Committee On Finance. on 03/11/2020
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 [HB-6074]
[Healthcare ]
[Small Business ]
[Public Health ]
[Disaster Relief ]
[Funding ]
[Grants ]
[International ]
[Medicare and Medicaid ]
[Budget and Spending ]
[Telecommunications ]
Provides $8.3 billion in emergency funding for federal agencies to respond to the coronavirus outbreak. DIVISION A--CORONAVIRUS PREPAREDNESS AND RESPONSE SUPPLEMENTAL APPROPRIATIONS ACT, 2020 Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 This division provides FY2020 supplemental appropriations for the Department of Health and Human Services (HHS), the State Department, and the Small Business Administration to respond to the coronavirus outbreak. The division funds programs that address issues such as developing, manufacturing,
(continued...)
HB-6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Sponsored by: Rep. Nita Lowey
Became Public Law No: 116-123. (txt | Pdf) on 03/06/2020
Coronavirus Vaccine Act [S.3370]
[Healthcare ]
[Public Health ]
[Science ]
Directs the National Institute of Allergy and Infectious Diseases to conduct or support research to develop a coronavirus vaccine.
S.3370: Coronavirus Vaccine Act
Sponsored by: Sen. Edward Markey
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/02/2020
SR-511: A resolution supporting the role of the United States in helping save the lives of children and protecting the health of people in developing countries with vaccines and immunization through GAVI, the Vaccine Alliance.
Sponsored by: Sen. Susan Collins
Resolution Agreed To In Senate With An Amendment And An Amended Preamble By Voice Vote. on 06/16/2020
You have voted SR-511: A resolution supporting the role of the United States in helping save the lives of children and protecting the health of people in developing countries with vaccines and immunization through GAVI, the Vaccine Alliance..
HR-861: Supporting the role of the United States in helping save the lives of children and protecting the health of people in poor countries with vaccines and immunization through the GAVI Alliance.
Sponsored by: Rep. Barbara Lee
Referred To The Subcommittee On Africa, Global Health, Global Human Rights, And International Organizations. on 04/03/2020
You have voted HR-861: Supporting the role of the United States in helping save the lives of children and protecting the health of people in poor countries with vaccines and immunization through the GAVI Alliance..
Robin Danielson Feminine Hygiene Product Safety Act of 2019 [HB-3865]
[Healthcare ]
[Public Health ]
[Science ]
[Consumer Protection ]
Requires the National Institutes of Health to conduct or support research on the extent to which components (including contaminants and substances used as fragrances, colorants, dyes, and preservatives) in feminine hygiene products pose health risks to women who use the products or to the children of women who use the products during or before pregnancy.
HB-3865: Robin Danielson Feminine Hygiene Product Safety Act of 2019
Sponsored by: Rep. Carolyn Maloney
Referred To The Subcommittee On Health. on 07/22/2019
Global Health Security Act of 2020 [S.3302]
[Healthcare ]
[Public Health ]
[International ]
[National Security ]
Establishes a permanent, presidentially appointed position to manage outbreak response efforts. Specifically, the bill establishes the role of Special Advisor for Global Health Security who shall (1) serve as the President's principal advisor on global health security and global health emergencies (2) coordinate U.S. efforts to carry out global health security activities, and (3) convene the Global Health Security Interagency Review Council. The bill establishes such council to provide policy guidance to participating agencies on global health security
(continued...)
S.3302: Global Health Security Act of 2020
Sponsored by: Sen. Angus King
Read Twice And Referred To The Committee On Foreign Relations. on 02/13/2020
Protecting Americans from Seasonal Influenza Act of 2020 [HB-5729]
[Healthcare ]
[Public Health ]
[Funding ]
[Grants ]
[Insurance ]
Requires the Centers for Disease Control and Prevention to award grants to increase seasonable influenza vaccination rates in states that have sustained influenza vaccination rates below recommended levels. State health agencies receiving such grants must include at least one of the elements set out in the bill in their programs. Among others, these include (1) increasing outreach to vulnerable populations, (2) encouraging employer-based vaccination programs, and (3) coordinating between health care providers and insurers to reduce out-of-pocket
(continued...)
HB-5729: Protecting Americans from Seasonal Influenza Act of 2020
Sponsored by: Rep. James Langevin
Introduced In House on 01/30/2020
National Biomedical Research Act [S.3161]
[Healthcare ]
[Science ]
[Funding ]
[Grants ]
[Public Health ]
A bill to establish the "Biomedical Innovation Fund", and for other purposes.
S.3161: National Biomedical Research Act
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 01/08/2020
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 [HB-5534]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Senior Citizens ]
Indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant.
HB-5534: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Sponsored by: Rep. Raul Grijalva
Reported (amended) By The Committee On Energy And Commerce. H. Rept. 116-687, Part I. on 12/24/2020
National Biomedical Research Act [HB-5400]
[Healthcare ]
[Science ]
[Funding ]
[Grants ]
[Pharmaceuticals ]
[Public Health ]
[Medicare and Medicaid ]
Establishes and makes deposits into the Biomedical Innovation Fund for initiatives at the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; (4) early-career scientists, including researchers from traditionally underrepresented groups;
(continued...)
HB-5400: National Biomedical Research Act
Sponsored by: Rep. David Loebsack
Referred To The Subcommittee On Health. on 12/12/2019
Lower Costs, More Cures Act of 2019 [HB-19]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Consumer Protection ]
[Budget and Spending ]
Establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs. The bill generally limits payment amounts for drugs and biologics under Medicare medical services, reduces cost-sharing under the Medicare prescription drug benefit, modifies certain authorities and requirements under the Medicaid Drug Rebate Program, revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and establishes several reporting requirements for drug manufacturers
(continued...)
HB-19: Lower Costs, More Cures Act of 2019
Sponsored by: Rep. Alexander Mooney
Referred To The Subcommittee On Antitrust, Commercial, And Administrative Law. on 12/19/2019
Protecting Seniors Through Immunization Act of 2019 [HB-5076]
[Healthcare ]
[Medicare and Medicaid ]
[Senior Citizens ]
[Pharmaceuticals ]
[Public Health ]
Specifies that certain deductible, coinsurance, initial coverage limit, and cost-sharing requirements that apply under the Medicare prescription drug benefit shall not apply with respect to vaccines that are recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention. The Centers for Medicare & Medicaid Services must provide to Medicare beneficiaries specified information regarding (1) coverage of vaccines for seniors, and (2) access to recommended vaccines without cost-sharing.
HB-5076: Protecting Seniors Through Immunization Act of 2019
Sponsored by: Rep. Raul Grijalva
Introduced In House on 11/13/2019